1. Xue Tian#, Lei Dong#, Ting-Ting Jiang#, Bo-Hao Tang, Ze-Ming Wang, Yue-E Wu, Dian-Ping You, Jing Bi, Su-Yun Qian*, Hui Qi*, A-Dong Shen* . Meropenem for children with severe pneumonia: Protocol for a randomized controlled trial.Frontiers in pharmacology.2022.13:1021661.1-8.SCI |
2. Qi Hui, Wu Yuee, Liu Yali, Kou Chen, Wang Zeming, Peng Xiaoxia, Chen liang, Cui hong, Wang Yajuan, Li Jieqiong, Zhao Wei*, Shen Adong*.Latamoxef for Neonates With Early-Onset Neonatal Sepsis: A Study Protocol for a Randomized Controlled Trial.Frontiers in Pharmacology.2021.12:635517.1-7.SCI |
3. Li Xue#, Qi Hui#, Jin Fei#, Yao Bufan, Wu Yuee, Qi Yujie, Kou Chen, Wu Xirong, Luo Xiaojing, Shen Yan-Hua, Zheng Xu, Wang Yonghong, Xu Fang, Jiao Weiwei, Li Jieqiong, Xiao Jing, Dong Yining, Du Bin, Shi Haiyan, Xu Baoping, Shen Adong*, Zhao Wei*.Population pharmacokinetics-pharmacodynamics of ceftazidime in neonates and young infants: Dosing optimization for neonatal sepsis.European Journal of Pharmaceutical Sciences.2021.163:105868 .1-8.SCI |
4. Xu Fang, Qi Hui, Li Jieqiong, Sun Lin, Gong Juanjuan, Chen Yuanying, Shen Adong*, Li Wei*.Mycobacterium tuberculosis infection up-regulates MFN2 expression to promote NLRP3 inflammasome formation.The Journal of Biological Chemistry.2020.295(51).17684-17697.SCI |
5. Hui Qi#, Chen Kou#, Yu-Jie Qi, Bo-Hao Tang, Yue-E Wu, Fei Jin, Xiao-Jing Luo, Yan-Hua Shen, Ya-Jie Guo, Xue Qi, Ya-Cui Wang, Qian Dong, Xing-Kai Chen, Hai-Yan Shi, Yi Zheng, Wei Zhao*, A-Dong Shen*.Population pharmacokinetics and dosing optimization of latamoxef in neonates and young infants.International journal of antimicrobial agents.2019.53(3).347-351.SCI |
6. Qi Hui#, Zhang Yongbiao#, Sun Lin#, Chen Cheng#, Xu Biao, Xu Fang, Liu Jiawen, Liu Jincheng, Chen Chen, Jiao Weiwei, Shen Chen, Xiao Jing, Li Jieqiong, Guo Yajie, Wang Yonghong, Li Qinjing, Yin Qingqin, Li Yingjia, Wang Ting, Wang Xingyun, Gu Mingliang, Yu Jun, Shen Adong*.Discovery of susceptibility loci associated with tuberculosis in Han Chinese.Human Molecular Genetics.2017.26(23).4752-4763.SCI |